Malignant neoplasm of lymphoid, hematopoietic and/or related tissue clinical trials
43 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
- Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
- αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
- An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
- Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
- Effectiveness of Central Oncology Navigation and the Use of an ORN
- Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
- PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
- Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
- Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation
- A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
- Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
- Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
- Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
- Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- Expressive Writing Program Among Young Adults With Blood Cancer
- ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
- Implementation of an Oral Chemotherapy Adherence Intervention
- Allergy Delabeling in Antibiotic Stewardship - Intervention
- Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial
- BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Diet and Cognitive Training in Hematologic Cancer Survivors
- Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
- Home Blood Transfusions
- Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
- HEME Home Transfusion Program
- Assessing DCog Short for Neurotoxicity in CAR-T
- Allergy Delabeling in Antibiotic Stewardship - Evaluations
- A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
- Long-Term Follow-up Study
- Screening for Hematology Branch Protocols
- AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
- Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
- A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy
- Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant neoplasm of lymphoid, hematopoietic and/or related tissue” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.